Home / Europe / United Kingdom / Life Sciences & Healthcare / Devices & Diagnostics

Devices & Diagnostics

Back to Life Sciences & Healthcare

In an increasingly competitive healthcare market, medical device and diagnostics companies need to ensure return on investment when developing innovative and reliable medical technologies and services. Devices and diagnostics are subject to complex regulatory and compliance frameworks and are often subject to competitive tendering.  You will need lawyers who can reliably advise on pragmatic, compliant solutions.

Through our team of sector specialists, we are well placed to advise throughout the product lifecycle from R&D, registration and commercialisation through to post-market support, transactional deals and litigation challenges.

We regularly advise device and diagnostics companies on their day-to-day business activities, including product development, registration, promotion and marketing (both B2B and B2C) and post-market responsibilities and liabilities. We also assist with licensing and commercial contracts, intellectual property enforcement,competition, anti-corruption and code compliance issues. 

Clients come to us for advice on both UK and international corporate deals, and we regularly represent manufacturers in complex litigation, including defence of product liability claims, and in pricing and procurement challenges. 

Medical technology companies expanding into e-health provision can rely on our strong technology, regulatory and data protection practices to tackle the full spectrum of legal challenges. Our teams regularly advise on the regulations applicable to digital health technologies, the associated data protection risks, as well as the commercialisation of e-health technologies and the regulatory frameworks for healthcare services. 

Via our significant involvement with industry bodies, such as the ABHI, BIVDA and MedTech Europe, we have helped shape the industry codes on business ethics, and we have significant experience of advising the industry on anti-corruption and code compliance issues. 

Highlights of our experience in Devices & Diagnostics in the UK
Johnson & Johnson on the UK aspects of the sale of the Ortho-Clinical Diagnostics (OCD) business to the Carlyle Group. PuriCore on the USD 26m sale of its British endoscopy subsidiary to Cantel Medical...
Law-Now: Lifesciences
Visit Law-Now for legal know-how and commentary
Advising the Board

Feed

04/06/2019
Future Leaders
We are pleased to invite you to the latest seminar in our 'Future Leaders Seminar Series' which is run by less senior members of our team for the benefit of junior in-house lawyers and other professionals...
29/11/2018
(Webinar) Vital Signs
The UK Life Sciences sector welcomed Sir John Bell’s Life Sciences Industrial Strategy last year. Its bold vision and ambition have the potential to drive a new era of growth. But as a new survey by...
19/09/2018
Future Leaders Seminar Series
We are pleased to announce the third seminar in our 'Future Leaders Seminar Series' which is run by less senior members of our team for the benefit of junior in-house lawyers and other professionals...
20/06/2018
Innovation in the Cloud - Reducing IP Risk for the Life Sciences and Healthcare...
New technologies like cloud computing are transforming the Life Sciences industry. Many businesses now incorporate data analytics and software development into their core operations. In the process, healthcare...
21/06/2017
Lifesciences Webinars: Spring Series 2017
We are delighted to invite you to the Spring Webinar Series hosted by the CMS Lifesciences Sector Group. The series has been designed to give you and your colleagues an overview of the legal aspects of...
21/06/2017
Lifesciences Webinars: Spring Series 2017
We are delighted to invite you to the Spring Webinar Series hosted by the CMS Lifesciences Sector Group. The series has been designed to give you and your colleagues an overview of the legal aspects of...
11/05/2017
Lifesciences Webinars: Spring Series 2017
We are delighted to invite you to the Spring Webinar Series hosted by the CMS Lifesciences Sector Group. The series has been designed to give you and your colleagues an overview of the legal aspects of...
15/12/2016
Webinar Series: Lifesciences 2016
On behalf of the CMS Lifesciences sector group, we are pleased to invite you to a series of webinars in which we will draw on experts from across the CMS network to give multi-jur­is­dic­tion­al views on...